The Human Anti-Crimean-Congo Hemorrhagic Fever Virus (CCHFV) IgM ELISA Kit detects and quantifies CCHFV -specific IgM in human serum or plasma of vaccinated, immunized and/or infected hosts. This immunoassay is suitable for:
_ Determining immune status relative to non- immune controls;
_ Assessing efficacy of vaccines, including dosage, adjuvantcy, route of immunization and timing;
_ Qualifying and standardizing vaccine batches & protocols.